TYPE 2 DIABETES (T2DM)
Clinical trials for TYPE 2 DIABETES (T2DM) explained in plain language.
Never miss a new study
Get alerted when new TYPE 2 DIABETES (T2DM) trials appear
Sign up with your email to follow new studies for TYPE 2 DIABETES (T2DM), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Can a 12-Week program reverse type 2 diabetes in family doctor offices?
Disease control ENROLLING_BY_INVITATIONThis study tests whether a short-term program combining health coaching and medication can help people with type 2 diabetes achieve remission without surgery. It involves 118 adults diagnosed within the last 5 years, recruited from a primary care clinic in Hamilton, Ontario. The …
Matched conditions: TYPE 2 DIABETES (T2DM)
Sponsor: McMaster University • Aim: Disease control
Last updated Jun 27, 2026 14:02 UTC
-
AI-Powered moroccan diet could help tame diabetes
Disease control OngoingThis study tests whether a diet plan based on traditional Moroccan foods, guided by artificial intelligence and continuous glucose monitors, can help adults with type 2 diabetes control their blood sugar. Fifty participants will wear a glucose monitor, keep food diaries, and rece…
Matched conditions: TYPE 2 DIABETES (T2DM)
Phase: NA • Sponsor: Avicenna Military Hospital • Aim: Disease control
Last updated Jun 27, 2026 09:04 UTC
-
Can intense workouts reverse diabetes risk after pregnancy?
Knowledge-focused ENROLLING_BY_INVITATIONThis study compares 20 women who had gestational diabetes with 20 who did not, all matched by age and weight. Researchers will measure body composition, insulin sensitivity, and other metabolic markers before and after 8 weeks of high-intensity interval training. The goal is to u…
Matched conditions: TYPE 2 DIABETES (T2DM)
Phase: NA • Sponsor: Odense University Hospital • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:29 UTC
-
New study explores best diabetes treatment for black patients
Knowledge-focused OngoingThis study looks at how two types of diabetes medicines affect the pancreas in Black patients with type 2 diabetes. About 60 adults will take either a GLP-1 receptor agonist or an SGLT-2 inhibitor for 16 weeks. The goal is to see which drug better helps the pancreas make insulin,…
Matched conditions: TYPE 2 DIABETES (T2DM)
Phase: PHASE4 • Sponsor: MaryAnn Banerji • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:09 UTC